AKERO THERAPEUTICS INC

CUSIP: 00973Y108 Class: Common Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 108,100 Value ($000) $5,133 Avg Close Range
Q2 2025
Shares 106,400 Value ($000) $5,678 Avg Close Range
Q1 2025
Shares 94,700 Value ($000) $3,833 Avg Close Range
Q4 2024
Shares 95,600 Value ($000) $2,660 Avg Close Range
Q3 2024
Shares 94,500 Value ($000) $2,711 Avg Close Range
Q2 2024
Shares 102,000 Value ($000) $2,393 Avg Close Range
Q1 2024
Shares 105,000 Value ($000) $2,652 Avg Close Range
Q4 2023
Shares 87,600 Value ($000) $2,045 Avg Close Range
Q3 2023
Shares 97,300 Value ($000) $4,921 Avg Close Range
Q2 2023
Shares 96,300 Value ($000) $4,496 Avg Close Range
Q1 2023
Shares 65,600 Value ($000) $2,510 Avg Close Range
Q4 2022
Shares 71,000 Value ($000) $3,891 Avg Close Range
Q3 2022
Shares 69,200 Value ($000) $2,356 Avg Close Range
Q2 2022
Shares 49,400 Value ($000) $467 Avg Close Range
Q1 2022
Shares 37,100 Value ($000) $526 Avg Close Range
Q4 2021
Shares 34,400 Value ($000) $728 Avg Close Range
Q3 2021
Shares 34,400 Value ($000) $769 Avg Close Range
Q2 2021
Shares 34,400 Value ($000) $853 Avg Close Range
Q1 2021
Shares 35,300 Value ($000) $1,024 Avg Close Range
Q4 2020
Shares 35,300 Value ($000) $911 Avg Close Range
Q3 2020
Shares 34,600 Value ($000) $1,065 Avg Close Range
Q2 2020
Shares 22,400 Value ($000) $558 Avg Close Range